Population Health Sciences

You are here

Publications

Found 57 results
[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HAlan, Schackman BR.  2016.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.. Health Aff (Millwood). 35(6):1045-51.
Bao Y, Fan G, Zou D, Wang T, Xue D.  2017.  Patient experience with outpatient encounters at public hospitals in Shanghai: Examining different aspects of physician services and implications of overcrowding.. PLoS One. 12(2):e0171684.
Bao Y, Eggman AA, Richardson JE, Sheeran TF, Bruce ML.  2015.  Practices of Depression Care in Home Health Care: Home Health Clinician Perspectives.. Psychiatr Serv. 66(12):1365-8.
Barfield E, Deshmukh F, Slighton E, Lentine J, Lu Y, Ma X, Christos PJ, Sockolow RE, Loughlin G, Pillai S.  2020.  Pulmonary Manifestations in Adolescents With Inflammatory Bowel Disease.. Clin Pediatr (Phila). :9922820910821.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Brown B, O'Donnell E, Casalino LP.  2019.  Private Equity Investment in Behavioral Health Treatment Centers.. JAMA Psychiatry.